Skip to main content
Premium Trial:

Request an Annual Quote

Hologic Buy of Gen-Probe Clears German Regulatory Review

NEW YORK (GenomeWeb News) – German regulators have cleared Hologic's $3.7 billion purchase of Gen-Probe, the two companies said today.

The deal, under which Hologic will pay $82.75 for each share of Gen-Probe stock, cleared US antitrust review last month and with clearance from Germany's Federal Cartel Office, required antitrust clearances have been received, the companies said.

The purchase is expected to be completed on or about Aug. 1. Gen-Probe is holding a special shareholders meeting on July 1 at its San Diego headquarter to vote on the deal.